Gail Matthews

17.5k total citations · 1 hit paper
219 papers, 5.8k citations indexed

About

Gail Matthews is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Gail Matthews has authored 219 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Hepatology, 159 papers in Epidemiology and 80 papers in Infectious Diseases. Recurrent topics in Gail Matthews's work include Hepatitis C virus research (169 papers), Hepatitis B Virus Studies (113 papers) and Liver Disease Diagnosis and Treatment (91 papers). Gail Matthews is often cited by papers focused on Hepatitis C virus research (169 papers), Hepatitis B Virus Studies (113 papers) and Liver Disease Diagnosis and Treatment (91 papers). Gail Matthews collaborates with scholars based in Australia, United States and United Kingdom. Gail Matthews's co-authors include Gregory J. Dore, Jason Grebely, Marianne Martinello, Andrew R. Lloyd, Mark Nelson, Margaret Hellard, Mark Danta, Sharon R. Lewin, Behzad Hajarizadeh and John Kaldor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Nature Immunology.

In The Last Decade

Gail Matthews

212 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

2022 584 citations Chansavath Phetsouphanh, D.R. Darley et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gail Matthews Australia	41	3.8k	3.7k	2.2k	508	474	219	5.8k
Arthur Y. Kim United States	38	2.7k 0.7×	3.3k 0.9×	1.2k 0.6×	209 0.4×	658 1.4×	121	4.9k
Nicola Coppola Italy	40	3.9k 1.0×	3.6k 1.0×	1.3k 0.6×	279 0.5×	102 0.2×	291	5.9k
Claudia Vellozzi United States	41	2.7k 0.7×	1.2k 0.3×	1.4k 0.6×	534 1.1×	118 0.2×	91	4.4k
Pablo Barreiro Spain	46	3.8k 1.0×	3.7k 1.0×	3.6k 1.6×	130 0.3×	1.6k 3.4×	331	7.3k
Kosh Agarwal United Kingdom	42	8.2k 2.1×	8.2k 2.2×	1.2k 0.5×	127 0.3×	131 0.3×	248	10.0k
Salvador Resino Spain	31	1.9k 0.5×	1.0k 0.3×	1.3k 0.6×	81 0.2×	1.1k 2.3×	297	4.1k
Sandro Vento Italy	31	1.9k 0.5×	1.6k 0.4×	738 0.3×	98 0.2×	191 0.4×	127	3.6k
Chiara Azzari Italy	38	2.7k 0.7×	1.3k 0.3×	733 0.3×	64 0.1×	160 0.3×	251	5.1k
Philippe Morlat France	33	1.8k 0.5×	953 0.3×	2.1k 0.9×	94 0.2×	1.0k 2.2×	109	4.2k
Fabrice Bonnet France	38	1.5k 0.4×	663 0.2×	2.1k 0.9×	197 0.4×	1.1k 2.4×	173	4.4k

Countries citing papers authored by Gail Matthews

Since Specialization

Citations

This map shows the geographic impact of Gail Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Matthews more than expected).

Fields of papers citing papers by Gail Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Matthews. The network helps show where Gail Matthews may publish in the future.

Co-authorship network of co-authors of Gail Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Gail Matthews. A scholar is included among the top collaborators of Gail Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Matthews. Gail Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilson, Douglas W., Sohaib Virk, A. Bhat, et al.. (2025). Evaluation of the Clinical Significance of Carotid Plaque Characteristics in Ischaemic Stroke: A Systematic Review and Meta-Analysis. Heart Lung and Circulation. 34(10). 1041–1049.

Burrows, Fay, et al.. (2024). Crossing the Turbulent Hepatitis Sea: Use of Prophylactic Glecaprevir/Pibrentasvir to Facilitate Cardiothoracic Transplants from Hepatitis C Viremic Donors in Australia. The Journal of Heart and Lung Transplantation. 43(4). S452–S452.

Singh, Kasha P., Anchalee Avihingsanon, Jennifer M. Zerbato, et al.. (2024). Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy. EBioMedicine. 102. 105054–105054. 3 indexed citations

Sacks‐Davis, Rachel, Daniela K van Santen, Michael W. Traeger, et al.. (2024). Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020. Liver International. 44(4). 1024–1031. 2 indexed citations

Petoumenos, Kathy, Margaret Borok, Nagalingeswaran Kumarasamy, et al.. (2024). Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study. Clinical Infectious Diseases. 80(1). 160–163. 2 indexed citations

Stewardson, Andrew J., Joshua S. Davis, Adrian Dunlop, Steven Y. C. Tong, & Gail Matthews. (2024). How I manage severe bacterial infections in people who inject drugs. Clinical Microbiology and Infection. 30(7). 877–882. 1 indexed citations

Sacks‐Davis, Rachel, Michael W. Traeger, Daniela K van Santen, et al.. (2024). Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data. Sexually Transmitted Infections. 100(5). 295–301. 1 indexed citations

Valerio, Heather, et al.. (2023). Cascade of care among people with hepatitis B in New South Wales, Australia. Journal of Viral Hepatitis. 30(12). 926–938. 4 indexed citations

Martinello, Marianne, Sanjay Bhagani, David Shaw, et al.. (2023). Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study. JHEP Reports. 5(10). 100867–100867. 4 indexed citations

10.

Manoharan, Lakshmi, Michael W. Traeger, Niklas Luhmann, et al.. (2023). Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis. Hepatology Communications. 7(4). 2 indexed citations

11.

Valerio, Heather, Maryam Alavi, Alison D. Marshall, et al.. (2023). Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population‐based study. Drug and Alcohol Review. 43(5). 1080–1092. 5 indexed citations

12.

Barbieri, Sebastiano, Evan B. Cunningham, Marc van der Valk, et al.. (2023). Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study. Journal of the International AIDS Society. 26(9). e26168–e26168. 3 indexed citations

13.

Phetsouphanh, Chansavath, D.R. Darley, Daniel B. Wilson, et al.. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature Immunology. 23(2). 210–216. 584 indexed citations breakdown →

14.

Barbieri, Sebastiano, et al.. (2022). National trends in retreatment of HCV due to reinfection or treatment failure in Australia. Journal of Hepatology. 78(2). 260–270. 8 indexed citations

15.

Yee, Jasmine, Behzad Hajarizadeh, James O’Beirne, et al.. (2021). High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study. Hepatology Communications. 6(3). 496–512. 12 indexed citations

16.

Martinello, Marianne, Janaki Amin, Gail Matthews, & Gregory J. Dore. (2017). Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis.. PubMed. 18(2). 68–80. 21 indexed citations

17.

Doyle, Joseph, Jason Grebely, Tim Spelman, et al.. (2016). Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort. PLoS ONE. 11(6). e0150655–e0150655. 13 indexed citations

18.

Martinello, Marianne, Maryam Alavi, Kenneth M. Williams, et al.. (2015). The Impact of Ribavirin Plasma Concentration on the Efficacy of the Interferon-Sparing Regimen, Sofosbuvir and Ribavirin. Antiviral Therapy. 21(2). 127–132. 3 indexed citations

19.

Martinello, Marianne, Margaret Hellard, David Shaw, et al.. (2014). Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II Study. Hepatology. 60. 1 indexed citations

20.

Dore, Gregory J., Margaret Hellard, Gail Matthews, et al.. (2009). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology. 138(1). 123–135.e2. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact